Key result
Adjunctive Korean medicine linked to ~31% lower triglycerides in a refractory hypertriglyceridemia case.
Why the study?
Does Korean medicine improve triglyceride levels in a quadriplegic patient with refractory hypertriglyceridemia?
Case Report (n=1)
No
Does Korean medicine improve triglyceride levels in a quadriplegic patient with refractory hypertriglyceridemia?
Korean medicine may serve as an effective adjunctive therapy for managing refractory hypertriglyceridemia in patients with severe physical disabilities who cannot undergo lifestyle modifications.
Should not yet change practice in refractory hypertriglyceridemia; leaves open adjunctive Korean medicine role pending controlled trials.
Introduction: Managing hypertriglyceridemia in patients with severe physical disabilities is challenging because lifestyle modifications are often not feasible. This case report describes a quadriplegic patient whose refractory hypertriglyceridemia was successfully managed with Korean medicine.Case Presentation: A 55-year-old man with quadriplegia due to intracerebral hemorrhage presented with severe hypertriglyceridemia. Despite maximal-dose conventional lipid-lowering therapy, his triglyceride levels remained poorly controlled, peaking at 726 mg/dL. After initiation of Korean medicine, triglyceride levels stabilized within the range of 468–539 mg/dL over 3 months. After discontinuation of Korean medicine, triglyceride levels surged to 771 mg/dL, leading to multiple complications, including acute biliary pancreatitis, hyperosmolar hyperglycemic state, and septic shock.Conclusion: This case suggests that Korean medicine may serve as an adjunctive therapy for refractory hypertriglyceridemia in patients for whom lifestyle interventions are limited.
No takes yet. Share an insight, caveat, or question.
You et al. (2026) conducted a case report in Refractory hypertriglyceridemia (n=1). Korean medicine (Chushi-huayu-gagam-tang and Liqi-hwan) vs. None (baseline comparison) was evaluated on Triglyceride levels. Korean medicine stabilized triglyceride levels from a peak of 726 mg/dL to a range of 468-539 mg/dL over 3 months in a quadriplegic patient with refractory hypertriglyceridemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: